Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-12 Sale | 2025-03-14 4:30 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER | 5,611 | $1.14 | $6,397 | 80,297 (Direct) | View |
| 2024-03-28 Sale | 2024-04-01 9:28 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER | 860 | $4.6495 | $3,999 | 71,908 (Direct) | View |
| 2024-03-25 Sale | 2024-03-27 6:57 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER | 1,350 | $4.67 | $6,305 | 72,768 (Direct) | View |
| 2023-06-07 Sale | 2023-06-09 4:25 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Scientific Officer | 9,273 | $12.03 | $111,526 | 60,118 (Direct) | View |
| 2023-06-06 Sale | 2023-06-07 4:55 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Scientific Officer | 1,200 | $12.04 | $14,448 | 69,391 (Direct) | View |
| 2022-03-15 Sale | 2022-03-16 4:04 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 533 | $11.3 | $6,023 | 46,041 (Direct) | View |
| 2021-11-15 Sale | 2021-11-17 7:46 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 20,000 | $27.33 | $546,613 | 533 (Direct) | View |
| 2021-08-16 Sale | 2021-08-20 4:24 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 15,000 | $33.99 | $509,886 | 20,533 (Direct) | View |
| 2021-05-17 Sale | 2021-05-18 5:53 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 15,000 | $32.71 | $490,710 | 35,533 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-04 Option Award | 2025-03-06 5:00 pm | N/A 2035-03-03 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER | 174,000 | $0 | 245,908 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 9:06 pm | N/A 2034-02-28 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER | 99,000 | $0 | 159,118 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 9:46 pm | N/A 2033-01-29 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Scientific Officer | 121,650 | $0 | 167,691 (Direct) | View |
| 2022-01-18 Exercise | 2022-01-20 4:42 pm | N/A 2032-01-17 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 115,000 | $0 | 115,000 (Direct) | View |
| 2021-11-23 Exercise | 2021-12-06 4:47 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 15,978 | $1.637 | 219,827 (Direct) | View |
| 2021-11-23 Exercise | 2021-12-06 4:47 pm | N/A 2027-06-14 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 46,041 | $0 | 219,827 (Direct) | View |
| 2021-11-23 Exercise | 2021-12-06 4:47 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 19,590 | $2.062 | 219,827 (Direct) | View |
| 2021-11-23 Exercise | 2021-12-06 4:47 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 10,473 | $2.425 | 219,827 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 9:05 pm | N/A 2031-02-08 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer | 125,000 | $0 | 125,000 (Direct) | View |